Exploring Drugs Targeting Neuroglial Disorders: A Comprehensive Overview

Abstract

Neurological  disorders affect the intricate network of cells in the central nervous  system (CNS) , along with  neurons and glial cereals.  Glial cells namely  atrocities, oligodendro cytes and microbial play an important violence in controlling  neural function, synaptic plasticity and overall CNS  homeostasis. Anti_ inflammatory  agents, namely NSAID and corticosteroids, have been explored for their potentiality in mitigating astrocyre _ mediated inflammation. Disease  modifying drugs  Including interferon and mono clonal antibodies, aim  to modulate  the immune  response  and decrease demyelination specifically  in multiple sclerosis patients.  Minocycline, an  antibiotic with anti_ inflammatory properties, has proved  beneficial effect in attenuating microbial activation  and decreases neuro inflammation in many  experimental models.  Targeting  glial fibrillary acidic protein ( GFAD ) , a marker for reactive atrocities has gained popularity.  Small molecules  and gene therapies aimed at modulating GFAP expression  exhibit promise in regulating  astrocyte reactivity  and potentially  decreasing the progression  of  neurological  disorders. Finally  it is concluded  that the exploration  of rugs  targeting neurological disorders represents a promising avenue particularly  in neuro science  research.